Jeffrey Schwartz is a member of our Board and has served in such role since 2023. He is also the chairman of our Board, a member of our compensation committee and the chair of our nominating and corporate governance committee. Mr. Schwartz currently serves as a Partner and Chief Operating Officer for Global Private Equity at Bain Capital Private Equity, LP. Prior to this role, Mr. Schwartz was a founding member and partner of Bain Capital Life Sciences. Before founding Bain Capital Life Sciences in 2016, he was a leader in the healthcare vertical of Bain Capital Private Equity, LP, where he focused on healthcare investments. Mr. Schwartz previously served on the board of directors of Rapid Micro Biosystems, Inc. (Nasdaq: RPID), SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), and BCLS Acquisition Corp. (a special purpose acquisition company). Mr. Schwartz holds an M.B.A. from the Wharton School at the University of Pennsylvania, where he was a Palmer Scholar, and holds a B.A. in economics from Yale University. We believe Mr. Schwartz is qualified to serve on our Board based on his over 20 years of experience in advising and supporting the growth and development of companies in the healthcare industry.